Litigation for gabapentin

US Court Litigation for gabapentin

Patent	Case Name	Docket	Date Filed	Date Terminated	Cause	Court	Jury Demand	Link To Docket
6,340,475		1:20-cv-20555|S.D. Fla.	2020-02-05	2020-02-17	28:1332 Diversity-Fraud	District Court, S.D. Florida	Plaintiff
6,340,475		1:23-cv-00199|D. Del.	2023-02-23			District Court, D. Delaware
6,340,475	Endo Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.	15-2021|Fed. Cir.	2015-09-15			Court of Appeals for the Federal Circuit
6,340,475	Purdue Pharma L.P. v. Depomed, Inc.	15-2029|Fed. Cir.	2015-09-15			Court of Appeals for the Federal Circuit
6,340,475		16-1378|Fed. Cir.	2015-12-30			Court of Appeals for the Federal Circuit
6,340,475	FWK Holdings, LLC v. Bausch Health Companies Inc.	3:19-cv-05426|N.D. Cal.	2019-08-29	2019-12-16	15:1 Antitrust Litigation	District Court, N.D. California	Plaintiff

Patent Trial and Appeal Board Cases for gabapentin

Patent	Petitioner	Status	Filing Date	Accorded Filing Date	Patent Owner	Trial Type	Trial Number	Decision Date	Inventor	Document Download
6,340,475	Purdue Pharma L.P.		2014-01-24	01-24-2014	Depomed, Inc.	Inter partes review		07-10-2014	JOHN SHELL
6,340,475	Purdue Pharma L.P.		2014-01-24	01-24-2014	Depomed, Inc.	Inter partes review		07-10-2014	JOHN SHELL
6,340,475	Endo Pharmaceutical Inc. et al.		2014-04-17	04-17-2014	Depomed, Inc.	Inter partes review		09-29-2014	JOHN SHELL
6,340,475	Endo Pharmaceutical Inc. et al.		2014-04-17	04-17-2014	Depomed, Inc.	Inter partes review		09-29-2014	JOHN SHELL
6,635,280	Purdue Pharma L.P.		2014-01-24	01-24-2014	DepoMed, Inc.	Inter partes review		07-10-2014	John Shell
6,635,280	Endo Pharmaceutical Inc. et al.		2014-04-17	04-17-2014	Depomed, Inc.	Inter partes review		09-29-2014	John Shell